Author | Martin H. Voss, MD | OncLive

Author | Martin H. Voss, MD

Articles

Dr. Voss on Phase I/II Trial Data of MEDI0680/Durvalumab Versus Nivolumab in mRCC

December 06, 2019

Video

Martin H. Voss, MD, discusses results of a randomized phase I/II trial looking at the combination of MEDI0680 and durvalumab (Imfinzi) versus nivolumab (Opdivo) in metastatic renal cell carcinoma.

Dr. Voss on the Case for Neoadjuvant Treatment in Kidney Cancer

February 06, 2018

Video

Martin H. Voss, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, explains the case for neoadjuvant therapy in the treatment of kidney cancer.

Dr. Voss Discusses Treatment in the Neoadjuvant Setting for Kidney Cancer

January 16, 2018

Video

Martin H. Voss, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses treatment in the neoadjuvant setting for patients with kidney cancer.

Dr. Voss on the Future of Clinical Trials for Kidney Cancer

December 26, 2017

Video

Martin H. Voss, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of the clinical trial space for patients with kidney cancer.

x